Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35347134.
- Also identified by DOI 10.1038/s41467-022-29164-0 and PMC identifier 8960779.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Intrahepatic cholangiocarcinoma (iCCA) is a highly heterogeneous cancer with limited understanding of its classification and tumor microenvironment. Here, by performing single-cell RNA sequencing on 144,878 cells from 14 pairs of iCCA tumors and non-tumor liver tissues, we find that S100P and SPP1 are two markers for iCCA perihilar large duct type (iCCA<sup>phl</sup>) and peripheral small duct type (iCCA<sup>pps</sup>). S100P + SPP1- iCCA<sup>phl</sup> has significantly reduced levels of infiltrating CD4<sup>+</sup> T cells, CD56<sup>+</sup> NK cells, and increased CCL18<sup>+</sup> macrophages and PD1<sup>+</sup>CD8<sup>+</sup> T cells compared to S100P-SPP1 + iCCA<sup>pps</sup>. The transcription factor CREB3L1 is identified to regulate the S100P expression and promote tumor cell invasion. S100P-SPP1 + iCCA<sup>pps</sup> has significantly more SPP1<sup>+</sup> macrophage infiltration, less aggressiveness and better survival than S100P + SPP1- iCCA<sup>phl</sup>. Moreover, S100P-SPP1 + iCCA<sup>pps</sup> harbors tumor cells at different status of differentiation, such as ALB + hepatocyte differentiation and ID3+ stemness. Our study extends the understanding of the diversity of tumor cells in iCCA.
Medical subject headings
- Bile Duct Neoplasms
- Cholangiocarcinoma